LEARN MORE ABOUT DR. BILAL BIN HAFEEZ

Community NewsNews
1343

Translate to Spanish or other 102 languages!

Graduate research assistants Emmanuel Anning, Godwin Peasah-Darkwah and Asif Shahriar work in the lab to assist in the development of a treatment for advanced pancreatic cancer. (UTRGV Image Office of Research & New Program Development)

Mega Doctor News

- Advertisement -

Hafeez is the founding member of the first nationally recognized South Texas Center of Excellence in Cancer Immunology at the UTRGV School of Medicine and is an accomplished researcher with a background in immunopharmacology, cancer therapeutics and cancer biology. Hafeez, a Nehtaur, Bijnor, Uttar Pradesh, India native, has earned prestigious grant awards and is an active member of the American Association for Cancer Research and the Indian Association for Cancer Research. His significant contributions to cancer biology and molecular therapeutics have led to his numerous published manuscripts in scientific journals. 

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
School of Medicine earns $1.45M grant for pancreatic cancer research
Next article
Nursing and Allied Health to host new conference dedicated to health careers for students

More Articles

STHS’ Step Up for Stroke Awareness and Prevention

Mega Doctor News McALLEN, Texas - Running May 16–22, the virtual 50,000 step challenge...

RGV College Celebrates Milestone Growth and Outstanding Outcomes of Its Apprenticeship Nursing Program

Rio Grande Valley College (RGVC) proudly celebrates a major milestone in the continued success of its Apprenticeship Nursing Program, the first program of its kind in the region.

The Secret to Morning Energy Isn’t Coffee—It’s Hydration

Mega Doctor News CLEVELAND CLINIC - When you first wake up, do you...

FDA Fast-Tracks Mental Health Treatments in Response to New Executive Order

President Trump on April 18 issued an Executive Order directing the U.S. Department of Health and Human Services to accelerate access to treatments for patients with serious mental illness, including devastating, complex, and treatment-resistant conditions.
- Advertisement -